From the Molecule to the Clinic — Inhibiting HER2 to Treat Breast Cancer
E. A. Eisenhauer
- 15 Mar, 2001
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
